Does PHARMA-BIO SERV, INC. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores PHARMA-BIO SERV, INC. (PBSV) 38.1 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 46, returns on capital 14, balance-sheet safety 55, capital discipline 45.

How has PBSV's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 38.1 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

PHARMA-BIO SERV, INC.

PBSV · Consumer Discretionary · $11.5M mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

No moat

The four filters

Pricing power46

Median gross margin 29.8% over 9y, stable.

Returns on capital14

Median ROIC -3.4%, above the 9% hurdle in 40% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline45

Owner earnings trend unclear, share count flat.

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): —
Est. intrinsic value / share: —
Recent price: $0.50
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for PBSV yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale38.1 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — PBSV has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Consumer Discretionary context

#226 of 340 scored Consumer Discretionary companies, ranked by Moat Score.

Nearest peers by Moat Score

#224LVLU Lulu's Fashion Lounge Holdings, Inc.38.3 out of 100, No moatNo moat
#225QVCAQ QVC GROUP, INC.38.2 out of 100, No moatNo moat
#227III Information Services Group Inc.38.1 out of 100, No moatNo moat
#228HOG Harley-Davidson, Inc.37.8 out of 100, No moatNo moat

Compare PBSV with its nearest peers →All Consumer Discretionary companies on the Index →

Common questions about PBSV

Does PHARMA-BIO SERV, INC. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores PHARMA-BIO SERV, INC. (PBSV) 38.1 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 46, returns on capital 14, balance-sheet safety 55, capital discipline 45.
How has PBSV's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 38.1 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows PBSV’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/PBSV"
  width="340" height="150" style="border:0"
  title="PBSV Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell PBSV. See the disclaimer.